IDEAS home Printed from https://ideas.repec.org/a/adp/jctoij/v10y2018i5p86-94.html
   My bibliography  Save this article

Frontline Treatment of Acute Myeloid Leukemia in Adults Long-Term Results in a Mexican Medical Center

Author

Listed:
  • Alvarado Ibarra Martha
  • Guerra Alarcón Lidia Virginia
  • Mena Zepeda Verónica
  • Ortiz Zepeda Maricela
  • Espitia Ríos Eugenia
  • à lvarez Vera José Luis
  • De la Peña Celaya Antonio
  • López Hernández Manuel Antonio

    (Hematology Service, National Medical Center, Mexico)

Abstract

Acute myeloid leukemias were previously known as a single disease, they are a heterogeneous group of diseases with different morphological characteristics and several genetic alterations that are related to prognosis, in general the five years overall survival for patients with de novo Acute Myeloid Leukemia (AML) is only 25% according to Surveillance, Epidemiology, and End Results Program (SEER) from United States of America. Standard chemotherapy for this type of leukemia with best results is those schemes based on cytarabine and anthracycline administration achieving Complete Response (CR) rates of 85%.

Suggested Citation

  • Alvarado Ibarra Martha & Guerra Alarcón Lidia Virginia & Mena Zepeda Verónica & Ortiz Zepeda Maricela & Espitia Ríos Eugenia & à lvarez Vera José Luis & De la Peña Celaya Antonio & López Hernán, 2018. "Frontline Treatment of Acute Myeloid Leukemia in Adults Long-Term Results in a Mexican Medical Center," Cancer Therapy & Oncology International Journal, Juniper Publishers Inc., vol. 10(5), pages 86-94, May.
    • Handle: RePEc:adp:jctoij:v:10:y:2018:i:5:p:86-94
    DOI: 10.19080/CTOIJ.2018.10.555800
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555800.pdf
    Download Restriction: no
    File URL: https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555800.php
    Download Restriction: no
    File URL: https://libkey.io/10.19080/CTOIJ.2018.10.555800?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Juliana Meyers & Yanni Yu & James Kaye & Keith Davis, 2013. "Medicare Fee-for-Service Enrollees with Primary Acute Myeloid Leukemia: An Analysis of Treatment Patterns, Survival, and Healthcare Resource Utilization and Costs," Applied Health Economics and Health Policy, Springer, vol. 11(3), pages 275-286, June.
    2. Jing Wang & Yong-Gong Yang & Min Zhou & Jing-Yan Xu & Qi-Guo Zhang & Rong-Fu Zhou & Bing Chen & Jian Ouyang, 2013. "Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin + Cytarabine with Daunorubicin + Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia," PLOS ONE, Public Library of Science, vol. 8(4), pages 1-9, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gabriel Tremblay & Clemence Cariou & Christian Recher & Mike Dolph & Patricia Brandt & Anne-Sandrine Blanc & Anna Forsythe, 2020. "Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 543-555, June.
    2. Qiang Gong & Lixin Zhou & Shuangnian Xu & Xi Li & Yunding Zou & Jieping Chen, 2015. "High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-14, May.
    3. Hyerim Ha & Yujin Jeong & Joo Han Lim & Young Ju Suh, 2022. "Treatment Pattern, Financial Burden, and Outcomes in Elderly Patients with Acute Myeloid Leukemia in Korea: A Nationwide Cohort Study," IJERPH, MDPI, vol. 19(4), pages 1-13, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:jctoij:v:10:y:2018:i:5:p:86-94. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.